Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Wednesday, March 4, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Public Health
Amazon’s algorithms boost vaccine misinformation, says study
Life Sciences Times
-
January 29, 2021
0
Pharma
Novavax Covid-19 vaccine found 89.3% effective
Life Sciences Times
-
January 29, 2021
0
Pharma
J&J single-shot Covid-19 vaccine shows 66% efficacy overall
Life Sciences Times
-
January 29, 2021
0
Venture Capital
Scitara Raises $5 Million to Accelerate Digital Transformation of Scientific Laboratories
Life Sciences Times
-
January 28, 2021
0
Life Sciences
Labcorp Earns 100 Percent on Human Rights Campaign Foundation’s Annual Scorecard on LGBTQ Workplace Equality
Life Sciences Times
-
January 28, 2021
0
Biotech
Cognito Therapeutics Appoints Mark Day as Chief Business Officer
Life Sciences Times
-
January 28, 2021
0
Real Estate
White Oak Healthcare Acquires 4 Class-A Medical Office Buildings in Ohio and Minnesota
Life Sciences Times
-
January 28, 2021
0
Biotech
Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester, UK
Life Sciences Times
-
January 28, 2021
0
Public Health
Guterres reiterates call for equitable access to Covid-19 vaccines
Life Sciences Times
-
January 28, 2021
0
Pharma
Pfizer-BioNTech Covid vax neutralises UK, South Africa variants
Life Sciences Times
-
January 28, 2021
0
1
...
786
787
788
...
805
Page 787 of 805
TOP AUTHORS
Life Sciences Times
8044 POSTS
0 Comments
https://blstimes.com
Most Read
Mobile Heartbeat Expands Banyan Platform Integration With Microsoft Teams to Improve Enterprise Communication
March 3, 2026
Syntis Bio Doses First Patient in Phase 1/1b Trial of Oral Obesity Drug SYNT-101, Expands Leadership Team
March 3, 2026
Poplar Therapeutics Raises $45 Million to Advance Anti-IgE Therapy for Food Allergy and Atopic Diseases
March 3, 2026
Amylyx Pharmaceuticals Narrows Losses in 2025 as Phase 3 Avexitide Trial Nears Completion
March 3, 2026